GSK3B and cancer: TWS119 is a specific inhibitor of GSK-3β which has been shown to inhibit cell proliferation and induce the apoptosis of human alveolar rhabdomyosarcoma cells [38], while it regulates epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) properties in triple-negative breast (TNB) cancer [39].